CHRDL1 and clear cell renal carcinoma: Additionally, CHRDL1 shows prognostic value in breast cancer (Wang et al., 2020), thyroid cancer (Pan et al., 2021; Ren et al., 2021), and clear cell renal carcinoma (Wu et al., 2023).